MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Structural MRI features of glucocerebrosidase (GBA)-associated Parkinson’s disease

R. Patel, T. Stoub, B. Cozzi, G. Pal (Chicago, USA)

Meeting: 2022 International Congress

Abstract Number: 1309

Keywords: Cognitive dysfunction, Magnetic resonance imaging(MRI), Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: To compare structural differences in brain magnetic resonance imaging (MRI) between Glucocerebrosidase (GBA) mutation carriers with Parkinson’s disease (PD-GBA) vs non-mutation carriers.

Background: PD-GBA patients who undergo subthalamic nucleus (STN) deep brain stimulation (DBS) may have accelerated cognitive decline compared to non-mutation carriers. In addition to its motor circuitry, the STN also has limbic and associative projections, which are thought to impact cognition and mood. In this study, we sought to compare structural differences in brain regions involved in STN limbic and cognitive circuitry between PD-GBA and non-mutation carriers.

Method: PD-GBA patients who underwent 3T brain MRI during work-up for DBS consideration at Rush University were included in the study, and controls were Parkinson’s disease (PD) DBS candidates without GBA mutation and were matched 1:1 by sex and age. We analyzed brain regions involved in STN limbic and associative circuitry including anterior cingulate, prefrontal cortex, orbitofrontal cortex, hippocampus, amygdala and others. Volumetric analysis was performed using FreeSurfer software. We compared group differences in normalized brain region volume and asymmetry index using mann-whitney test, and linear regression was performed amongst PD-GBA patients to assess asymmetry index with baseline cognitive function. p-value < 0.05 was considered significant.

Results: Ten PD-GBA patients and 10 non-carrier controls were included in the study. Baseline characteristics were similar. There was no difference in normalized brain region volume between the two groups, however asymmetry index of ventrolatral prefrontal cortex (vlPRF) in PD-GBA vs PD non-GBA patients was -0.03 +/- 0.04 vs -0.001 +/- 0.05, respectively (p=0.1), though our study was under-powered to detect significant difference. In PD-GBA patients, there was a moderate correlation between mean asymmetry index of vlPFC and baseline cognitive function (r=0.73, p=0.016).

Conclusion: Structural differences in brain regions involved with STN limbic and associative circuitry may explain some of the cognitive differences between PD-GBA and non-mutation carriers.

To cite this abstract in AMA style:

R. Patel, T. Stoub, B. Cozzi, G. Pal. Structural MRI features of glucocerebrosidase (GBA)-associated Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/structural-mri-features-of-glucocerebrosidase-gba-associated-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/structural-mri-features-of-glucocerebrosidase-gba-associated-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley